INVIVO THERAPEUTICS (NVIVQ, $0.37) was a top loser over the last three months, falling -4 to $0.37 per share. A.I.dvisor analyzed 913 stocks in the Biotechnology Industry for the 3-month period ending April 26, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend. 655 similar cases when NVIVQ's price dropped within three months. In out of those 655 cases, NVIVQ's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for NVIVQ are